Seher Yildiz Tacar (Seher Yıldız Tacar)

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Ejection Fraction

Combination Therapy

Acute Kidney Injury

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Seher Yildiz Tacar, Mesut Yilmaz, Buge Oz, Deniz Tural
Crizotinib for c-MET-amplified advanced NSCLC: a single-center experience. Tumori (2021)
Ilkay Gulturk, Mesut Yilmaz, Aykut Ozmen, Seher Yildiz Tacar, Gülçin Sahingoz Erdal, Deniz Tural
Ribociclib induced acute kidney injury: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Osman Sütçüoğlu, Ayşegül İlhan, Seher Yildiz Tacar, Deniz Can Guven, Gokhan Ucar, Nuri Karadurmus, Fatih Yildiz, Emrah Eraslan, Doğan Uncu, Deniz Tural, Aytuğ Üner, Nazan Günel, Nuriye Ozdemir, Saadettin Kılıçkap, Ömür Berna Çakmak Öksüzoğlu, Ahmet Özet, Ozan Yazıcı
Thirty-day mortality rates after immunotherapy initiation. Immunotherapy 13 (17) (2021)